Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_3
3
38%
Ph phase_4
1
13%
Ph phase_1
4
50%

Phase Distribution

4

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
4(50.0%)
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Terminated(1)

Detailed Status

Completed7
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (50.0%)
Phase 33 (37.5%)
Phase 41 (12.5%)

Trials by Status

withdrawn113%
completed788%

Recent Activity

0 active trials
Showing 5 of 8
withdrawnphase_4

Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder

NCT00878748
completedphase_1

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study

NCT01282814
completedphase_1

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

NCT01282801
completedphase_1

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions

NCT01260896
completedphase_1

Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand Preparations

NCT00676039
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00878748Phase 4

Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder

Withdrawn
NCT01282814Phase 1

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study

Completed
NCT01282801Phase 1

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

Completed
NCT01260896Phase 1

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions

Completed
NCT00676039Phase 1

Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand Preparations

Completed
NCT00225485Phase 3

Study Evaluating Effexor XR in Elderly Patients With Major Depression.

Completed
NCT00225524Phase 3

Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.

Completed
NCT00225511Phase 3

Study Evaluating Effexor XR for Major Depression.

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8